Interwest Partners led the financing and existing investors PureTech Ventures participated. The funding is expected to take the company through a clinical proof of concept study.
Rox Anderson, professor of dermatology at Harvard Medical School, and co- founder and Scientific Advisory Board Chair of Follica, said: “Our technologies for creating and manipulating hair follicles position us to treat, and perhaps eventually cure, androgenetic alopecia, other hair loss conditions, and related follicular disorders such as acne.”